Barrios V - Search Results

1

Role of telemedicine in the management of oral anticoagulation in atrial fibrillation: a practical clinical approach.

Barrios V, Cinza-Sanjurjo S, García-Alegría J, Freixa-Pamias R, Llordachs-Marques F, Molina CA, Santamaría A, Vivas D, Suárez Fernandez C. Barrios V, et al. Future Cardiol. 2022 Sep;18(9):743-754. doi: 10.2217/fca-2022-0044. Epub 2022 Jul 13. Future Cardiol. 2022. PMID: 35822847 Free article. Review.

2

Patients with atrial fibrillation in a primary care setting: Val-FAAP study.

Barrios V, Calderón A, Escobar C, de la Figuera M; Primary Care Group in the Clinical Cardiology Section of the Spanish Society of Cardiology. Barrios V, et al. Rev Esp Cardiol (Engl Ed). 2012 Jan;65(1):47-53. doi: 10.1016/j.recesp.2011.08.008. Epub 2011 Nov 4. Rev Esp Cardiol (Engl Ed). 2012. PMID: 22054913 English, Spanish.

3

New evidences for old concerns with oral anticoagulation in atrial fibrillation: focus on dabigatran.

Barrios V, Escobar C. Barrios V, et al. Expert Opin Pharmacother. 2012 Dec;13(18):2649-61. doi: 10.1517/14656566.2012.749860. Epub 2012 Nov 20. Expert Opin Pharmacother. 2012. PMID: 23167273 Review.

4

Can dabigatran improve blood pressure control?

Barrios V, Escobar C. Barrios V, et al. Future Cardiol. 2013 May;9(3):321-3. doi: 10.2217/fca.13.18. Future Cardiol. 2013. PMID: 23668738

5

Prevalence of renal dysfunction according to the type of atrial fibrillation and anticoagulation treatment in patients who attended primary care in Spain.

Barrios V, Escobar C, Calderón A, Zamorano JL. Barrios V, et al. Future Cardiol. 2014 Mar;10(2):215-20. doi: 10.2217/fca.14.2. Future Cardiol. 2014. PMID: 24762248

6

Anticoagulation Control in Patients With Nonvalvular Atrial Fibrillation Attended at Primary Care Centers in Spain: The PAULA Study.

Barrios V, Escobar C, Prieto L, Osorio G, Polo J, Lobos JM, Vargas D, García N. Barrios V, et al. Rev Esp Cardiol (Engl Ed). 2015 Sep;68(9):769-76. doi: 10.1016/j.rec.2015.04.017. Epub 2015 Jul 11. Rev Esp Cardiol (Engl Ed). 2015. PMID: 26169326

7

Atrial fibrillation and chronic kidney disease: focus on rivaroxaban.

Barrios V, Górriz JL. Barrios V, et al. J Comp Eff Res. 2015 Nov;4(6):651-64. doi: 10.2217/cer.15.44. Epub 2015 Sep 21. J Comp Eff Res. 2015. PMID: 26388302 Free article.

8

Evaluation of SAMe-TT2R2 score and other clinical factors influencing the quality of anticoagulation therapy in non-valvular atrial fibrillation: a nationwide study in Spain.

Lobos-Bejarano JM, Barrios V, Polo-García J, Escobar C, Vargas-Ortega D, Marín-Montañés N, Prieto-Valiente L, Fuentes S, Prieto MA, García-Ortiz L; on behalf the PAULA Study Team. Lobos-Bejarano JM, et al. Among authors: barrios v. Curr Med Res Opin. 2016 Jul;32(7):1201-7. doi: 10.1185/03007995.2016.1164676. Epub 2016 Apr 7. Curr Med Res Opin. 2016. PMID: 26967541

9

Clinical benefits of pitavastatin: focus on patients with diabetes or at risk of developing diabetes.

Barrios V, Escobar C. Barrios V, et al. Future Cardiol. 2016 Jul;12(4):449-66. doi: 10.2217/fca-2016-0018. Epub 2016 Apr 14. Future Cardiol. 2016. PMID: 27076402 Review.

10

Implications of edoxaban in the prevention and treatment of thromboembolic complications in clinical practice.

Barrios V, Escobar C. Barrios V, et al. Future Cardiol. 2016 Jul;12(4):419-33. doi: 10.2217/fca-2016-0021. Epub 2016 Apr 28. Future Cardiol. 2016. PMID: 27121025 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

518 results

Search Page